Literature DB >> 26804710

Safe and efficient method for cryopreservation of human induced pluripotent stem cell-derived neural stem and progenitor cells by a programmed freezer with a magnetic field.

Yuichiro Nishiyama1, Akio Iwanami2, Jun Kohyama3, Go Itakura3, Soya Kawabata2, Keiko Sugai2, Soraya Nishimura2, Rei Kashiwagi2, Kaori Yasutake2, Miho Isoda4, Morio Matsumoto2, Masaya Nakamura5, Hideyuki Okano6.   

Abstract

Stem cells represent a potential cellular resource in the development of regenerative medicine approaches to the treatment of pathologies in which specific cells are degenerated or damaged by genetic abnormality, disease, or injury. Securing sufficient supplies of cells suited to the demands of cell transplantation, however, remains challenging, and the establishment of safe and efficient cell banking procedures is an important goal. Cryopreservation allows the storage of stem cells for prolonged time periods while maintaining them in adequate condition for use in clinical settings. Conventional cryopreservation systems include slow-freezing and vitrification both have advantages and disadvantages in terms of cell viability and/or scalability. In the present study, we developed an advanced slow-freezing technique using a programmed freezer with a magnetic field called Cells Alive System (CAS) and examined its effectiveness on human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs). This system significantly increased cell viability after thawing and had less impact on cellular proliferation and differentiation. We further found that frozen-thawed hiPSC-NS/PCs were comparable with non-frozen ones at the transcriptome level. Given these findings, we suggest that the CAS is useful for hiPSC-NS/PCs banking for clinical uses involving neural disorders and may open new avenues for future regenerative medicine.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Allogeneic transplantation; Cells Alive System (CAS); Central nervous system (CNS) disorder; Cryopreservation; Human iPSC-derived neural stem/progenitor cells (hiPSC-NS/PCs); Magnetic field; Neurosphere; Spinal cord injury (SCI)

Mesh:

Year:  2016        PMID: 26804710     DOI: 10.1016/j.neures.2015.11.011

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  7 in total

Review 1.  Cell therapy for spinal cord injury using induced pluripotent stem cells.

Authors:  Narihito Nagoshi; Osahiko Tsuji; Masaya Nakamura; Hideyuki Okano
Journal:  Regen Ther       Date:  2019-06-13       Impact factor: 3.419

2.  Progress in the Use of Induced Pluripotent Stem Cell-Derived Neural Cells for Traumatic Spinal Cord Injuries in Animal Populations: Meta-Analysis and Review.

Authors:  Christina Ramotowski; Xianggui Qu; Luis G Villa-Diaz
Journal:  Stem Cells Transl Med       Date:  2019-03-22       Impact factor: 6.940

3.  Differentiation of Human iPS Cells Into Sensory Neurons Exhibits Developmental Stage-Specific Cryopreservation Challenges.

Authors:  Rui Li; Patrick Walsh; Vincent Truong; Ashley Petersen; James R Dutton; Allison Hubel
Journal:  Front Cell Dev Biol       Date:  2021-12-14

4.  Evaluation of changes arising in the pig mesenchymal stromal cells transcriptome following cryopreservation and Trichostatin A treatment.

Authors:  Artur Gurgul; Joanna Romanek; Klaudia Pawlina-Tyszko; Tomasz Szmatoła; Jolanta Opiela
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

Review 5.  Hydrogel Cryopreservation System: An Effective Method for Cell Storage.

Authors:  Chaocan Zhang; Youliang Zhou; Li Zhang; Lili Wu; Yanjun Chen; Dong Xie; Wanyu Chen
Journal:  Int J Mol Sci       Date:  2018-10-25       Impact factor: 5.923

Review 6.  Novel test strategies for in vitro seizure liability assessment.

Authors:  Anke M Tukker; Remco H S Westerink
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-02-17       Impact factor: 4.481

7.  Cryopreservation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurospheres for Clinical Application.

Authors:  Satoe Hiramatsu; Asuka Morizane; Tetsuhiro Kikuchi; Daisuke Doi; Kenji Yoshida; Jun Takahashi
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.